Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.
The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.
Price-to-book ratio is used to compared the company's current market price with its book value.
These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.
Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.
Company Details
Check out the key parameters of the company to understand the financial health and stock performance
-
TechnicalThe key levels help you plan your entry and exit point.
-
Profit & LossTake a quick look at the revenues and expenditure sheet.
-
Balance SheetIts a statement of assets, liabilities and share capital.
-
Dividend HistoryCheck out the detailed payout data over the last three years.
-
Comparative ReturnsReveals how the stock has fared compared to the BSE, NSE benchmark indices.
Key Level
-
-
-
-
Moving Average
-
-
-
-
Growth in 3 years
Sales Industry Avg
PAT
PAT Industry Avg
Growth in 3 years
26.45%
Total Liabilities growth
9.50%
Reserves Change
-6.41%
Relative to Nifty rtn in 3 year
Relative to top 3 MF rtn in 3 year
2016 | 2014 | 2014 | |
---|---|---|---|
Sales | 59.91 | 59.91 | 59.91 |
Gross Profit | 60.14 | 60.14 | 60.14 |
Operating Profit | 6.14 | 6.14 | 6.14 |
Sales | 59.91 | 59.91 | 59.91 |
Gross Profit | 60.14 | 60.14 | 60.14 |
Operating Profit | 6.14 | 6.14 | 6.14 |
Peer Companies
A quick glance on how stocks from the same sector have performed along with some key parameters
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
one电竞直播app下载网址
Stocks and sector-wise Research Reports by one电竞(新疆)在线登录 securities help you analyse, understand and take a informed investment decision.
Report
Corporate Action
Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.
Our Research Analysis
18.2 %
Target Achived
+22.8 %
Buy Call with 3 month time frame
Rationale
History
15
jan 2016 |
Call initiated
Cmp: 1875 |
Target: 1875 | Reco: 1875 | Stop loss: 1875 | Upside: 1875 |
15
jan 2016 |
Call initiated
Cmp: 1875 |
Target: 1875 | Reco: 1875 | Stop loss: 1875 | Upside: 1875 |
15
jan 2016 |
Call initiated
Cmp: 1875 |
Target: 1875 | Reco: 1875 | Stop loss: 1875 | Upside: 1875 |
__PERCENT__ %
Target Achived
Potential Upside
__TARGETRETURN__ %
Buy Call with __TIMEFRAME__ time frame
__Rationale__
__DATE__
__MONTHYEAR__ |
Call initiated
Target: __TARGET__ |
Target Gain __TG__ % | Reco Price: __RP__ | Stop loss: __SL__ | HORIZON : __HORIZN__ |
FnO
A snapshot on how the stock has performed in the derivatives segment on a real-time basis.
__DaysLow__
__DaysHigh__
__DaysOpen__
__PreviousClose__
__Volume__
__OI__
__OIPer__
MF Holdings
Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.
Scheme Name | AUM (%) | CMV ( in Cr.) | Holding Date |
---|---|---|---|
Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
Aditya Birla Nuvo Ltd | 35.67 | 35.67 | 35.67 |
News
Stay tuned to the latest developments and happenings in the company.
Cipla receives USFDA approval for Lenalidomide Capsule
Cipla announced that it has received final approval for its Abbreviated New Drug Application (ANDA) for Lenalidomide Capsule 5 mg, 10 mg, 15 mg and 25....
07 Sep 2022 15:44Cipla announces dissolution of step-down subsidiary
Cipla announced that Cipla Med pro Holdings, wholly owned subsidiary of Cipla Med pro South Africa and a wholly owned step-down subsidiary of the Comp....
27 Aug 2022 11:06Cipla allots 3,444 equity shares under ESOP
Cipla has allotted 3,444 equity shares under ESOP on 17 August 2022. Consequently, the issued, subscribed and paid-up share capital of the Company sta....
17 Aug 2022 15:24Cipla consolidated net profit declines 3.96% in the June 2022 quarter
Net profit of Cipla declined 3.96% to Rs 686.40 crore in the quarter ended June 2022 as against Rs 714.72 crore during the previous quarter ended June....
29 Jul 2022 17:37Cipla consolidated net profit declines 12.41% in the March 2022 quarter
Net profit of Cipla declined 12.41% to Rs 362.07 crore in the quarter ended March 2022 as against Rs 413.38 crore during the previous quarter ended Ma....
11 May 2022 08:10Cipla consolidated net profit declines 2.61% in the December 2021 quarter
Net profit of Cipla declined 2.61% to Rs 728.60 crore in the quarter ended December 2021 as against Rs 748.15 crore during the previous quarter ended ....
27 Jan 2022 08:17__heading__
Published on __date__ at __time__
__description__
Corporate News
newsletter